Dr. Maria R. Tria Tirona
Claim this profileEdwards Comprehensive Cancer Center
Expert in Lung Cancer
Expert in Cancer
34 reported clinical trials
94 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Cancer
Global LeaderStage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Maria R. Tria Tirona is currently running
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
More about Maria R. Tria Tirona
Clinical Trial Related4 years of experience running clinical trials · Led 34 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Maria R. Tria Tirona has experience with
- Pembrolizumab
- Biospecimen Collection
- Carboplatin
- Paclitaxel
- Gemcitabine Hydrochloride
- Nivolumab
Breakdown of trials Maria R. Tria Tirona has run
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maria R. Tria Tirona specialize in?
Maria R. Tria Tirona focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Maria R. Tria Tirona currently recruiting for clinical trials?
Yes, Maria R. Tria Tirona is currently recruiting for 14 clinical trials in Huntington West Virginia. If you're interested in participating, you should apply.
Are there any treatments that Maria R. Tria Tirona has studied deeply?
Yes, Maria R. Tria Tirona has studied treatments such as Pembrolizumab, Biospecimen Collection, Carboplatin.
What is the best way to schedule an appointment with Maria R. Tria Tirona?
Apply for one of the trials that Maria R. Tria Tirona is conducting.
What is the office address of Maria R. Tria Tirona?
The office of Maria R. Tria Tirona is located at: Edwards Comprehensive Cancer Center, Huntington, West Virginia 25701 United States. This is the address for their practice at the Edwards Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.